Stay updated on Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial
Sign up to get notified when there's something new on the Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial page.

Latest updates to the Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA consolidated 'Locations' section listing multiple state sites (Alabama, California, Florida, Georgia, Illinois, Louisiana, Missouri, New York, North Carolina, Texas, Washington) was added, replacing the previous state-specific headings; the 'HHS Vulnerability Disclosure' link was removed and the page revision updated to v3.3.3.SummaryDifference1.0%

- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.3.2 is now displayed at the bottom of the page, replacing v3.3.1; no substantive study details or trial data are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check49 days agoChange DetectedPublications section now notes that items are automatically filled from PubMed and may not be about the study. The Revision label was updated to v3.3.1 (from v3.2.0).SummaryDifference0.1%

- Check56 days agoChange DetectedRemoval of the government funding and operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check70 days agoChange DetectedNo substantive changes detected to the page content. Core study details, eligibility criteria, and locations appear unchanged.SummaryDifference0.3%

- Check99 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

Stay in the know with updates to Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone Monotherapy in Bipolar Depression Global Clinical Trial page.